Incannex Healthcare (IXHL) Income towards Parent Company (2022 - 2026)

Incannex Healthcare (IXHL) posted quarterly Income towards Parent Company of -$3.9 million for Q1 2026, up 2.14% year-on-year from -$3.8 million in Q1 2025, and up 40.45% on a QoQ basis from -$6.5 million in Q4 2025.

Incannex Healthcare (IXHL) Income towards Parent Company (2022 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Income towards Parent Company for 5 consecutive years, with -$3.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Income towards Parent Company rose 2.14% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.4 million (down 122.97% YoY) and the FY2025 annual result came in at -$46.9 million, down 154.0% from the prior year.
  • Income towards Parent Company rose to -$3.9 million in Q1 2026 per IXHL's latest filing, from -$6.5 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for IXHL reached as high as -$726000.0 in Q3 2023 and fell as low as -$31.6 million in Q2 2025.
  • A 5-year average of -$6.6 million and a median of -$5.3 million in 2023 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2024 — Income towards Parent Company slumped 646.56% — and 2025, when it soared 34.21%.
  • Year by year, Income towards Parent Company stood at -$2.9 million in 2022, then tumbled by 79.61% to -$5.2 million in 2023, then declined by 12.46% to -$5.9 million in 2024, then retreated by 10.64% to -$6.5 million in 2025, then surged by 40.45% to -$3.9 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$3.9 million, -$6.5 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Incannex Healthcare 37.29 Mn 37.29 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.88 Mn
Dec 31, 2025 -6.52 Mn
Sep 30, 2025 -6.41 Mn
Jun 30, 2025 -31.60 Mn
Mar 31, 2025 -3.97 Mn
Dec 31, 2024 -5.89 Mn
Sep 30, 2024 -5.42 Mn
Jun 30, 2024 -6.43 Mn
Mar 31, 2024 -6.03 Mn
Dec 31, 2023 -5.24 Mn
Sep 30, 2023 -726,000.00
Jun 30, 2023 -4.17 Mn
Mar 31, 2023 -3.57 Mn
Dec 31, 2022 -2.92 Mn